The pharmaceutical membrane filtration market size is estimated to grow at a robust CAGR during the forecast period, 2021-2028. The growth of market is attributed to the growing demand and increasing adoption of single use technology and rising demand for nano-filtration.
Membrane filtration is the process of physically separating method characterized by the propensity in differentiating molecules varies in sizes and characteristics. Its force is the difference in pressure between two sides of the membrane.
Membrane technology covers almost all the verticals of industrial approach, the process performed by machine for separation of gaseous or liquid streams uses membrane technology. Comparative to other form of separation processes such as crystallization, sublimation, and distillation membrane separation uses less energy and operates without heating.
From the last few years the adoption of single-use technologies has been increased drastically, there has been advancement in nano-filtration technology owing to its massive demand in the healthcare and pharmaceutical industry for filtration.
Due to COVID-19 outbreak several biopharmaceuticals firm globally are working night and day to develop the vaccine for the novel coronavirus. To encourage and support healthcare segment numerous government and equity acquisition has been created.
Market Trends, Drivers, Restraints, and Opportunities
- Increasing demand for single use technology is expected to boost the market in the coming years.
- Rising demand for nano filtration is estimated to drive the market during the forecast period.
- Awareness about the process being more efficient and consume less energy is anticipated to drive the market during the projected period.
- Increasing good manufacturing by the manufacturers is one of the major factors boosting the market in the coming years.
- High cost of operation incurred by the manufacturers prevents from adopting technology this acts as major factor that can hinder the market growth.
- Maintenance procedure such as membrane fouling by the manufacturers possesses a challenge that can hamper the market growth in the coming years.
Scope of the market
The report global pharmaceutical membrane filtration market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Pharmaceutical membrane filtration market – Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
Materials (Nylon Membrane Filters, Polythersulfone (PES), Mixed Cellulose Ester & Cellulose Acetate (MCE & CA), Polyvinylidene Difluoride (PVDF), Others), Techniques (Nanofiltration, Ultrafiltration, Microfiltration, Others), Applications (Raw Material Filtration, Final Product Filtration. Cell Separation, Water Purification, Air Purification)
North America [United States, Canada, Mexico], Europe [United Kingdom, Italy, Spain, Germany, France, Rest of Europe], Asia Pacific [Japan, China, India, South Korea, Australia, Rest of Asia Pacific]
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
Key Players Covered in the Report
3M; Danaher Corporation; GE Healthcare; Mereck Millipore; Thermo Fisher Scientific.
Market Segment Insights
The mixed cellulose ester & cellulose acetate (MCE & CA) segment holds a large market share
On the basis of materials, the market is segregated into nylon membrane filters, polythersulfone (PES), mixed cellulose ester & cellulose acetate (MCE & CA), polyvinylidene difluoride (PVDF), and others. The mixed cellulose ester & cellulose acetate (MCE & CA) segment holds a large market share owing to increasing rate of adoption for membrane filtration products.
The microfiltration segment is estimates to constitute key share of the market
Based on techniques, the market is segregated into nanofiltration, ultrafiltration, microfiltration, and others. The microfiltration segment is estimated to constitute key share of the market due to increased usage in pharmaceutical industry for drug development with the help of widely used processes such as separating, concentrating, and colliding particles from solution.
The final product processing segment is expected to exhibit high CAGR
In the terms of application, the market is bifurcated into raw material filtration, final product filtration, cell separation, water purification, and air purification. The final product processing segment is expected to exhibit high CAGR owing to drastic growth in biopharmaceutical segment, sterile filtration, growing adoption of membrane filtration for protein purification, and rapid increase in the production of generics act as the drivers that boost the segment.
North America is expected to dominate the market
On the basis of region, the market is segregated into North America [United States, Canada, and Mexico], Europe [United Kingdom, Italy, Spain, Germany, France, and Rest of Europe], and Asia Pacific [Japan, China, India, South Korea, Australia, and Rest of Asia Pacific]. North America is expected to dominate the market during the forecast period due to high demand for the biopharmaceuticals in some part of the region and extensive rise in the R&D expenditure by biopharmaceuticals companies of North America.
The global pharmaceutical membrane filtration market has been segregated on the basis of
- Nylon Membrane Filters
- Polythersulfone (PES)
- Mixed Cellulose Ester & Cellulose Acetate (MCE & CA)
- Polyvinylidene Difluoride (PVDF)
- Raw Material Filtration
- Final Product Filtration
- Cell Separation
- Water Purification
- Air Purification
- North America
- United States
- United Kingdom
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Danaher Corporation
- GE Healthcare
- Mereck Millipore
- Thermo Fisher Scientific
Key players competing global pharmaceutical membrane filtration market include 3M; Danaher Corporation; GE Healthcare; Mereck Millipore; Thermo Fisher Scientific.
Some of these players are targeting on business strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to increase their market shares. For instance
In August 2021, Danaher Corporation completes acquisition process of Aldevron and announced operates solely as a brand within Danaher Corporation Danaher’s Life sciences.